Inspire Medical Systems, Inc. (INSP) delivered a loss per share of 34 cents in first-quarter 2024, narrower than the year-ago period’s loss of 53 cents per share. The metric was also narrower than the Zacks Consensus Estimate of a loss of 63 cents per share.Revenues in DetailInspire Medical registered revenues of $164 million in the first quarter, up 28.2% year over year. The figure beat the Zacks Consensus Estimate by 1.5%.Per management, the top-line growth was driven by increased market penetration in ex ...

For the quarter ended March 2024, Inspire Medical Systems (INSP) reported revenue of $164.01 million, up 28.2% over the same period last year. EPS came in at -$0.34, compared to -$0.53 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $161.63 million, representing a surprise of +1.47%. The company delivered an EPS surprise of +46.03%, with the consensus EPS estimate being -$0.63.While investors scrutinize revenue and earnings changes year-over-year and how they compare ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Ezgi Yagci - VP, IR Tim Herbert - Chairman and CEO Rick Buchholz - CFO Conference Call Participants Danielle Antalffy - UBS Travis Steed - Bank of America Adam Maeder - Piper Sandler Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Anthony Petrone - Mizuho Chris Pasquale - Nephron Richard Newitter - Truist Securities Shagun Singh - RBC John Block - Stifel Mike Kratky - Leerink Partne ...

Inspire Medical Systems (INSP) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.53 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 46.03%. A quarter ago, it was expected that this maker of devices for treating obstructive sleep apnea would post a loss of $0.04 per share when it actually produced earnings of $0.49, delivering a surprise of 1,32 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Inspire ...

Exhibit 99.1 Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook Inspire Reports Year-over-Year Revenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, Minnesota - May 7, 2024 - Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported f ...

Inspire Reports Year-over-YearRevenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2024. Recent Business Highlights Generated revenue of $164.0  ...

MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024. Inspire is scheduled to present at 7:20 p.m. Eastern Time. The presentation will be accessible via a live webcast ...

Inspire Medical Systems, Inc. (INSP) has been gaining from its focus on research and development (R&D). The optimism led by a solid fourth-quarter 2023 performance and its global presence are expected to contribute further. However, concerns regarding overdependence on the Inspire system and a competitive landscape prevail.Over the past year, this Zacks Rank #1 (Strong Buy) stock has lost 8.1% compared with the 21.8% decline of the industry. The S&P 500 has witnessed 21.7% growth in the said time frame.The ...

Inspire Medical Systems (INSP) shares rallied 9.9% in the last trading session to close at $243.51. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 8.4% gain over the past four weeks.Shares of the company surged likely in anticipation of improved earnings for its first quarter results scheduled to release on May 07, 2024. Loss estimates for the first quarter have narrowed in the past 30 days.This maker of dev ...